327 results on '"Krabbe, S"'
Search Results
102. Examination of thyroid function during iodine supplementation in normal thyroid state
- Author
-
MENG, W., primary, MENG, S., additional, HAMPEL, R., additional, KRABBE, S., additional, WEBER, A., additional, and VENTZ, M., additional
- Published
- 1988
- Full Text
- View/download PDF
103. Fundamental voice frequency measured by electroglottography during continuous speech. A new exact secondary sex characteristic in boys in puberty
- Author
-
Pedersen, M.F., primary, Møller, S., additional, Krabbe, S., additional, and Bennett, P., additional
- Published
- 1986
- Full Text
- View/download PDF
104. Red cell Na-K-ATPase in human obesity
- Author
-
KRABBE, S., primary, BRACHMANN, O., additional, and MENG, W., additional
- Published
- 1989
- Full Text
- View/download PDF
105. Evaluation of the combined test of hypothalamio-pituitary function
- Author
-
Petersen, K E, primary, Jacobsen, B Brock, additional, Kastrup, K W, additional, and Krabbe, S, additional
- Published
- 1981
- Full Text
- View/download PDF
106. 58 EVALUATION OF GROWTH AND ENDOCRINE FUNCTIONS AFTER BONE MARROW TRANSPLANTATION (BMI) FOR MALIGNANCIES
- Author
-
Krabbe, S, primary, Müller, J, additional, Børch, K, additional, and Yssing, M, additional
- Published
- 1988
- Full Text
- View/download PDF
107. Myelofibrosis and T3-thyreotoxicosis in a girl with McCune-Albright Syndrome
- Author
-
Peitersen, B, primary, Hertz, H, additional, Jacobsen, B Brock, additional, and Krabbe, S, additional
- Published
- 1981
- Full Text
- View/download PDF
108. Actions of thyrotropin-releasing-hormone (TRH) on glucose tolerance
- Author
-
MENG, W., primary, KRABBE, S., additional, HAMPEL, R., additional, MÄNNCHEN, E., additional, and KNOKE, M., additional
- Published
- 1986
- Full Text
- View/download PDF
109. Serum Lactate Dehydrogenase and its Isoenzymes in Men with Maldescended Testes
- Author
-
von Eyben, F.E., primary, Skude, G., additional, and Krabbe, S., additional
- Published
- 1982
- Full Text
- View/download PDF
110. URINARY STEROID PROFILE IN CHILDHOOD CUSHING'S DISEASE
- Author
-
Nielsen, M Damkjær, primary, Petersen, K E, additional, and Krabbe, S, additional
- Published
- 1988
- Full Text
- View/download PDF
111. Dr Krabbe and co-workers comment
- Author
-
Krabbe, S, primary, Christiansen, C, additional, Rodbro, P, additional, and Transbol, I, additional
- Published
- 1980
- Full Text
- View/download PDF
112. Alpha-foetoprotein and human chorionic gonadotropin in men with maldescended testes
- Author
-
von Eyben, F, primary, Krabbe, S, additional, and Skakkebæk, N E, additional
- Published
- 1980
- Full Text
- View/download PDF
113. PRECOCIOUS PUBERTY AND PITUITARY TUMOUR IN PRIMARY HYPOTHYROIDISM. EFFECT OF THYROXINE AND IMPLICATIONS FOR THE PATHOGENESIS
- Author
-
Krabbe, S, primary
- Published
- 1986
- Full Text
- View/download PDF
114. Prevention of adult height and bone mineral deficits in delayed male puberty with short stature.
- Author
-
Krabbe, S, primary, Transbol, I, additional, and Christiansen, C, additional
- Published
- 1980
- Full Text
- View/download PDF
115. 138 ADVERSE CHANCES IN SERUM BONE GLA-PROTEIN (BGP) AND ALKALINE PHOSPHATASE (AP) IN PRECOCIOUS PUBERTY (PP) DURING THERAPY
- Author
-
Thøger Nielsen, C, primary, Krabbe, S, additional, Johansen, Julia S, additional, and Skakkebæk, N E, additional
- Published
- 1988
- Full Text
- View/download PDF
116. A Multivariate Statistical Analysis of Voice Phenomena Related to Puberty in Choir Boys
- Author
-
Pedersen, M.F., primary, Møller, S., additional, Krabbe, S., additional, Munk, E., additional, and Bennett, P., additional
- Published
- 1985
- Full Text
- View/download PDF
117. Asymmetric Syntheses of Megacerotonic Acid and Shimobashiric Acid A.
- Author
-
KRABBE, S. W. and JOHNSON, J. S.
- Published
- 2015
- Full Text
- View/download PDF
118. Effect of puberty on rates of bone growth and mineralisation.
- Author
-
STEENDIJK, R., KRABBE, S., CHRSTIANSEN, C., RØDBRO, P., and TRANSBØL, I.
- Published
- 1980
- Full Text
- View/download PDF
119. 138 ADVERSE CHANCES IN SERUM BONE GLAPROTEIN BGP AND ALKALINE PHOSPHATASE AP IN PRECOCIOUS PUBERTY PP DURING THERAPY
- Author
-
Nielsen, C. Thøger, Krabbe, S., Johansen, Julia S., and Skakkebæk, N. E.
- Published
- 1988
120. Evaluation of the combined test of hypothalamiopituitary function
- Author
-
PETERSEN, K. E., JACOBSEN, B. BROCK, KASTRUP, K. W., and KRABBE, S.
- Published
- 1981
121. Myelofibrosis and T3thyreotoxicosis in a girl with McCuneAlbright Syndrome
- Author
-
PEITERSEN, B., HERTZ, H., JACOBSEN, B. BROCK, and KRABBE, S.
- Published
- 1981
122. Effect of Online Training on the Reliability of Assessing Sacroiliac Joint Radiographs in Axial Spondyloarthritis: A Randomized, Controlled Study.
- Author
-
Hadsbjerg AEF, Østergaard M, Paschke J, Micheroli R, Pedersen SJ, Ciurea A, Nissen MJ, Bubova K, Wichuk S, de Hooge M, Krabbe S, Mathew AJ, Gregová M, Wetterslev M, Gorican K, Pintaric K, Snoj Z, Möller B, Bernatschek A, Donzallaz M, Lambert RG, and Maksymowych WP
- Abstract
Objective: Radiographic assessment of sacroiliac joints (SIJs) according to the modified New York (mNY) criteria is key in the classification of axial spondyloarthritis but has moderate interreader agreement. We aimed to investigate the improvements of the reliability in scoring SIJ radiographs after applying an online real-time iterative calibration (RETIC) module, in addition to a slideshow and video alone., Methods: Nineteen readers, randomized to 2 groups (A or B), completed 3 calibration steps: (1) review of manuscripts, (2) review of slideshow and video with group A completing RETIC, and (3) re-review of slideshow and video with group B completing RETIC. The RETIC module gave instant feedback on readers' gradings and continued until predefined reliability (κ) targets for mNY positivity/negativity were met. Each step was followed by scoring different batches of 25 radiographs (exercises I to III). Agreement (κ) with an expert radiologist was assessed for mNY positivity/negativity and individual lesions. Improvements by training strategies were tested by linear mixed models., Results: In exercises I, II, and III, mNY κ were 0.61, 0.76, and 0.84, respectively, in group A; and 0.70, 0.68, and 0.86, respectively, in group B (ie, increasing, mainly after RETIC completion). Improvements were observed for grading both mNY positivity/negativity and individual pathologies, both in experienced and, particularly, inexperienced readers. Completion of the RETIC module in addition to the slideshow and video caused a significant κ increase of 0.17 (95% CI 0.07-0.27; P = 0.002) for mNY-positive and mNY-negative grading, whereas completion of the slideshow and video alone did not (κ = 0.00, 95% CI -0.10 to 0.10; P = 0.99)., Conclusion: Agreement on scoring radiographs according to the mNY criteria significantly improved when adding an online RETIC module, but not by slideshow and video alone.
- Published
- 2024
- Full Text
- View/download PDF
123. Lessons on predictive learning from the honeybee.
- Author
-
Krabbe S
- Subjects
- Bees physiology, Animals, Humans, Learning physiology
- Published
- 2024
- Full Text
- View/download PDF
124. Analysis of PM 2.5 , black carbon, and trace metals measurements from the Kansas City Transportation and Local-Scale Air Quality Study (KC-TRAQS).
- Author
-
Duvall RM, Kimbrough ES, Krabbe S, Deshmukh P, Baldauf RW, Brouwer LH, McArthur T, Croghan C, Varga J, Brown M, and Davis M
- Subjects
- Kansas, Cities, Air Pollution analysis, Transportation, Vehicle Emissions analysis, Trace Elements analysis, Particulate Matter analysis, Air Pollutants analysis, Environmental Monitoring methods, Soot analysis, Metals analysis
- Abstract
Communities near transportation sources can be impacted by higher concentrations of particulate matter (PM) and other air pollutants. Few studies have reported on air quality in complex urban environments with multiple transportation sources. To better understand these environments, the Kansas City Transportation and Local-Scale Air Quality Study (KC-TRAQS) was conducted in three neighborhoods in Southeast Kansas City, Kansas. This area has several emissions sources including transportation (railyards, vehicles, diesel trucks), light industry, commercial facilities, and residential areas. Stationary samples were collected for 1-year (October 24, 2017, to October 31, 2018) at six sites using traditional sampling methods and lower-cost air sensor packages. This work examines PM less than 2.5 μm in diameter (PM
2.5 ), black carbon (BC), and trace metals data collected during KC-TRAQS. PM2.5 filter samples showed the highest 24-h mean concentrations (9.34 μg/m3 ) at the sites located within 20-50 m of the railyard. Mean 24-h PM2.5 concentrations, ranging from 7.96 to 9.34 μg/m3 , at all sites were lower than that of the nearby regulatory site (9.83 μg/m3 ). Daily maximum PM2.5 concentrations were higher at the KC-TRAQS sites (ranging from 25.31 to 43.76 μg/m3 ) compared to the regulatory site (20.50 μg/m3 ), suggesting short-duration impacts of localized emissions sources. Across the KC-TRAQS sites, 24-h averaged PM2.5 concentrations from the sensor package (P-POD) ranged from 3.24 to 5.69 µg/m3 showing that, out-of-the-box, the PM sensor underestimated the reference concentrations. KC-TRAQS was supplemented by elemental and organic carbon (EC/OC) and trace metal analysis of filter samples. The EC/OC data suggested the presence of secondary organic aerosol formation, with the highest mean concentrations observed at the site within 20 m of the railyard. Trace metals data showed daily, monthly, and seasonal variations for iron, copper, zinc, chromium, and nickel, with elevated concentrations occurring during the summer at most of the sites. Implications : This work reports on findings from a year-long air quality study in Southeast Kansas City, Kansas to understand micro-scale air quality in neighborhoods impacted by multiple emissions sources such as transportation sources (including a large railyard operation), light industry, commercial facilities, and residential areas. While dozens of studies have reported on air quality near roadways, this work will provide more information on PM2.5 , black carbon, and trace metals concentrations near other transportation sources in particular railyards. This work can also inform additional field studies near railyards.- Published
- 2024
- Full Text
- View/download PDF
125. Detection of structural lesions of the sacroiliac joints in patients with spondyloarthritis: A comparison of T1-weighted 3D spoiled gradient echo MRI and MRI-based synthetic CT versus T1-weighted turbo spin echo MRI.
- Author
-
Krabbe S, Møller JM, Hadsbjerg AEF, Ewald A, Hangaard S, Pedersen SJ, and Østergaard M
- Subjects
- Humans, Female, Male, Prospective Studies, Cross-Sectional Studies, Adult, Middle Aged, Spondylarthritis diagnostic imaging, Magnetic Resonance Imaging methods, Sacroiliac Joint diagnostic imaging, Imaging, Three-Dimensional methods, Tomography, X-Ray Computed methods
- Abstract
Objectives: To investigate the detection of erosion, sclerosis and ankylosis using 1 mm 3D T1-weighted spoiled gradient echo (T1w-GRE) MRI and 1 mm MRI-based synthetic CT (sCT), compared with conventional 4 mm T1w-TSE., Materials and Methods: Prospective, cross-sectional study. Semi-coronal 4 mm T1w-TSE and axial T1w-GRE with 1.6 mm slice thickness and 0.8 mm spacing between overlapping slices were performed. The T1w-GRE images were processed into sCT images using a commercial deep learning algorithm, BoneMRI. Both were reconstructed into 1 mm semi-coronal images. T1w-TSE, T1w-GRE and sCT images were assessed independently by 3 expert and 4 non-expert readers for erosion, sclerosis and ankylosis. Cohen's kappa for inter-reader agreement, exact McNemar test for lesion frequencies and Wilcoxon signed-rank test for confidence in lesion detection were used., Results: Nineteen patients with axial spondyloarthritis were evaluated. T1w-GRE increased inter-reader agreement for detecting erosion (kappa 0.42 vs 0.21 in non-experts), increased detection of erosion (57 vs 43 of 152 joint quadrants) and sclerosis (26 vs 17 of 152 joint quadrants) among experts, and increased reader confidence for scoring erosion and sclerosis. sCT increased inter-reader agreement for detecting sclerosis (kappa 0.69 vs 0.37 in experts) and ankylosis (0.71 vs 0.52 in non-experts), increased detection of sclerosis (34 vs 17 of 152 joint quadrants) and ankylosis (20 vs 13 of 76 joint halves) among experts, and increased reader confidence for scoring erosion, sclerosis and ankylosis., Conclusion: T1w-GRE and sCT increase sensitivity and reader confidence for the detection of erosion, sclerosis and ankylosis, compared with T1w-TSE., Clinical Relevance Statement: These methods improve the detection of sacroiliac joint structural lesions and might be a useful addition to SIJ MRI protocols both in routine clinical care and as structural outcome measures in clinical trials., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
126. Epigenetic control of memory formation.
- Author
-
Krabbe S
- Subjects
- Animals, Humans, Mice, Histones metabolism, Acetylation, Epigenesis, Genetic, Memory, Neurons physiology, Neurons metabolism, Protein Processing, Post-Translational
- Abstract
A neuron's suitability to participate in a memory trace is modulated by its epigenetic state.
- Published
- 2024
- Full Text
- View/download PDF
127. Cell type specificity for circuit output in the midbrain dopaminergic system.
- Author
-
Blaess S and Krabbe S
- Subjects
- Animals, Dopaminergic Neurons physiology, Mammals, Mesencephalon metabolism, Brain
- Abstract
Midbrain dopaminergic neurons are a relatively small group of neurons in the mammalian brain controlling a wide range of behaviors. In recent years, increasingly sophisticated tracing, imaging, transcriptomic, and machine learning approaches have provided substantial insights into the anatomical, molecular, and functional heterogeneity of dopaminergic neurons. Despite this wealth of new knowledge, it remains unclear whether and how the diverse features defining dopaminergic subclasses converge to delineate functional ensembles within the dopaminergic system. Here, we review recent studies investigating various aspects of dopaminergic heterogeneity and discuss how development, behavior, and disease influence subtype characteristics. We then outline what further approaches could be pursued to gain a more inclusive picture of dopaminergic diversity, which could be crucial to understanding the functional architecture of this system., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
128. Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
- Author
-
Østergaard M, van Vollenhoven RF, Rudin A, Hetland ML, Heiberg MS, Nordström DC, Nurmohamed MT, Gudbjornsson B, Ørnbjerg LM, Bøyesen P, Lend K, Hørslev-Petersen K, Uhlig T, Sokka T, Grondal G, Krabbe S, Lindqvist J, Gjertsson I, Glinatsi D, Kapetanovic MC, Aga AB, Faustini F, Parmanne P, Lorenzen T, Giovanni C, Back J, Hendricks O, Vedder D, Rannio T, Grenholm E, Ljoså MK, Brodin E, Lindegaard H, Söderbergh A, Rizk M, Kastbom A, Larsson P, Uhrenholt L, Just SA, Stevens DJ, Bay Laurbjerg T, Bakland G, Olsen IC, Haavardsholm EA, and Lampa J
- Subjects
- Humans, Certolizumab Pegol therapeutic use, Abatacept therapeutic use, Methotrexate therapeutic use, Drug Therapy, Combination, Treatment Outcome, Antirheumatic Agents adverse effects, Arthritis, Rheumatoid diagnostic imaging, Arthritis, Rheumatoid drug therapy, Arthritis, Rheumatoid chemically induced
- Abstract
Background: The optimal first-line treatment in early rheumatoid arthritis (RA) is debated. We compared clinical and radiographic outcomes of active conventional therapy with each of three biological treatments with different modes of action., Methods: Investigator-initiated, randomised, blinded-assessor study. Patients with treatment-naïve early RA with moderate-severe disease activity were randomised 1:1:1:1 to methotrexate combined with (1) active conventional therapy: oral prednisolone (tapered quickly, discontinued at week 36) or sulfasalazine, hydroxychloroquine and intra-articular glucocorticoid injections in swollen joints; (2) certolizumab pegol; (3) abatacept or (4) tocilizumab. Coprimary endpoints were week 48 Clinical Disease Activity Index (CDAI) remission (CDAI ≤2.8) and change in radiographic van der Heijde-modified Sharp Score, estimated using logistic regression and analysis of covariance, adjusted for sex, anticitrullinated protein antibody status and country. Bonferroni's and Dunnet's procedures adjusted for multiple testing (significance level: 0.025)., Results: Eight hundred and twelve patients were randomised. Adjusted CDAI remission rates at week 48 were: 59.3% (abatacept), 52.3% (certolizumab), 51.9% (tocilizumab) and 39.2% (active conventional therapy). Compared with active conventional therapy, CDAI remission rates were significantly higher for abatacept (adjusted difference +20.1%, p<0.001) and certolizumab (+13.1%, p=0.021), but not for tocilizumab (+12.7%, p=0.030). Key secondary clinical outcomes were consistently better in biological groups. Radiographic progression was low, without group differences.The proportions of patients with serious adverse events were abatacept, 8.3%; certolizumab, 12.4%; tocilizumab, 9.2%; and active conventional therapy, 10.7%., Conclusions: Compared with active conventional therapy, clinical remission rates were superior for abatacept and certolizumab pegol, but not for tocilizumab. Radiographic progression was low and similar between treatments., Trial Registration Number: NCT01491815., Competing Interests: Competing interests: MØ received the study drug from BMS and UCB; research grants from Abbvie, BMS, Merck, Novartis and UCB; speaker fees from Abbvie, BMS, Celgene, Eli-Lilly, Galapagos, Gilead, Janssen, MEDAC, Merck, Novartis, Pfizer, Sandoz, and UCB; and consultancy fees from Abbvie, BMS, Celgene, Eli-Lilly, Galapagos, Gilead, Janssen, MEDAC, Merck, Novartis, Pfizer, Sandoz and UCB. RFvV received the study drug from BMS and UCB; research grants from BMS, GSK, UCB and AstraZeneca; consulting fees from AbbVie, AstraZeneca, Biogen, BMS, Galapagos, Janssen, Miltenyi, Pfizer and UCB; expert fees from AbbVie, Galapagos, GSK, Janssen, Pfizer, R-Pharma and UCB; and advisory board fees from AbbVie, AstraZeneca, Biogen, BMS, Galapagos, Janssen, Miltenyi, Pfizer and UCB. MLH received research grants from AbbVie, Biogen, BMS, Celtrion, Eli Lily, Janssen Biologics B.V., Lundbeck Foundation, MSD, Pfizer, Roche, Samsung Biopies, Sandoz and Novartis; and institution pay from Pfizer, Medac, AbbVie and Sandoz; chaired the steering committee of the Danish Rheumatology Quality Registry (DANBIO), which receives public funding from the hospital owners and funding from pharmaceutical companies; cochairs EuroSpA, which generates real-world evidence of treatment of psoriatic arthritis and axial spondylorthritis based on secondary data and is partly funded by Novartis. DCN received consulting fees from AbbVie, BMS, Lilly, MSD, Novartis, Pfizer, Roche and UCB' meeting support from Pfizer; advisory board participation fee from Novartis; and other service fee by BMS. MTN received research grants from AbbVie, BMS, Pfizer, Galapagos, Amgen and Eli Lily. BG received consulting fee from Novartis and honorary lecture payment from Novartis and Nordic-Pharma. IG received royalty fee for book authorship and support for attending meetings by EULAR. DG received advisory board fee from Eli Lily and AbbVie and speakers fee from Eli Lily. A-BA received speakers fee from AbbVie, Eli Lily, Novartis and Pfizer. CG received the study drug from BMS and UCB. MKL received advisory board fee from AbbVie. AS received advisory board fee from GSK (institution pay). LU received speakers fee from Janssen and support for meeting/travel from AbbVie and Eli Lily. DJS received honorarium fee from UCB (not a part of this, unrelated medication). GB received consultancy fee from UCB. ICO received research grants from EU Horizon 2020 and EU Horizon Europe, advisory board participation from IMPRESS-Norway, ALPHA2PREVENT, FLECAPRO and EVOLVD, and meeting/travel support from European Clinical Research Infrastructure Network. The remaining authors declared no disclosures., (© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2023
- Full Text
- View/download PDF
129. Performance of an MRI scoring system for inflammation of joints and entheses in peripheral SpA: post-hoc analysis of the CRESPA trial.
- Author
-
Krabbe S, Renson T, Jans L, Elewaut D, Van den Bosch F, Carron P, and Østergaard M
- Subjects
- Humans, Reproducibility of Results, Inflammation diagnostic imaging, Inflammation drug therapy, Joints, Magnetic Resonance Imaging, Severity of Illness Index, Osteitis diagnostic imaging, Osteitis drug therapy
- Abstract
Objectives: The aim of this study was to investigate the reliability, validity, and sensitivity to change of a novel MRI scoring system in early peripheral SpA (pSpA)., Methods: MRI of the pelvis and lower extremities was performed before initiation of the TNF inhibitor golimumab in 56 patients and repeated in 46 patients who achieved sustained clinical remission after 24, 36 or 48 weeks. Three readers applied a semi-quantitative MRI scoring system for lower-extremity joint and entheseal inflammation. Four lesion types were assessed: entheseal osteitis, entheseal soft-tissue inflammation, joint osteitis, and joint synovitis/effusion. MRI response was defined as a decrease in MRI lower-extremity inflammation index (sum of scores from 75 sites, each scored 0-3) above the smallest detectable change (SDC)., Results: At follow-up, the MRI index decreased in 34 of 46 patients (74%), and 15 (33%) patients achieved MRI response, i.e. a decrease above SDC of 2.8. When restricting the analysis to patients with clinical involvement of lower-extremity sites that were assessed by MRI, 13 of 28 (46%) achieved MRI response. Interreader reliability was very good, with an average-measure intraclass correlation coefficient of 0.92 (95% CI: 0.85-0.95) for status scores and 0.89 (0.80-0.94) for change in scores. The MRI index correlated with other measures of disease activity, including CRP [Spearman's rho 0.41 (0.23-0.56)], swollen joint count of 6 joints [0.47 (0.27-0.63)], tender enthesis count of 14 entheses [0.32 (0.12-0.50)] and pain score [0.28 (0.08-0.46)], all P < 0.05., Conclusion: The proposed MRI lower-extremity inflammation index demonstrated reliability, validity, and sensitivity to change in patients with early pSpA., Trial Registration: Clinicaltrials.gov, http://clinicaltrials.gov, NCT01426815., (© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
130. Multimodal mapping of cell types and projections in the central nucleus of the amygdala.
- Author
-
Wang Y, Krabbe S, Eddison M, Henry FE, Fleishman G, Lemire AL, Wang L, Korff W, Tillberg PW, Lüthi A, and Sternson SM
- Subjects
- In Situ Hybridization, Fluorescence, Neurons physiology, Axons, Neural Pathways metabolism, Central Amygdaloid Nucleus physiology
- Abstract
The central nucleus of the amygdala (CEA) is a brain region that integrates external and internal sensory information and executes innate and adaptive behaviors through distinct output pathways. Despite its complex functions, the diversity of molecularly defined neuronal types in the CEA and their contributions to major axonal projection targets have not been examined systematically. Here, we performed single-cell RNA-sequencing (scRNA-seq) to classify molecularly defined cell types in the CEA and identified marker genes to map the location of these neuronal types using expansion-assisted iterative fluorescence in situ hybridization (EASI-FISH). We developed new methods to integrate EASI-FISH with 5-plex retrograde axonal labeling to determine the spatial, morphological, and connectivity properties of ~30,000 molecularly defined CEA neurons. Our study revealed spatiomolecular organization of the CEA, with medial and lateral CEA associated with distinct molecularly defined cell families. We also found a long-range axon projection network from the CEA, where target regions receive inputs from multiple molecularly defined cell types. Axon collateralization was found primarily among projections to hindbrain targets, which are distinct from forebrain projections. This resource reports marker gene combinations for molecularly defined cell types and axon-projection types, which will be useful for selective interrogation of these neuronal populations to study their contributions to the diverse functions of the CEA., Competing Interests: YW, SK, ME, FH, GF, AL, LW, WK, PT, AL, SS No competing interests declared, (© 2023, Wang et al.)
- Published
- 2023
- Full Text
- View/download PDF
131. Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictors.
- Author
-
Terslev L, Ostergaard M, Georgiadis S, Brahe CH, Ellegaard K, Dohn UM, Fana V, Møller T, Juul L, Huynh TK, Krabbe S, Ornbjerg LM, Glinatsi D, Røgind H, Hansen A, Nørregaard J, Jacobsen S, Jensen DV, Manilo N, Asmussen K, Boesen M, Rastiemadabadi Z, Morsel-Carlsen L, Møller JM, Krogh NS, and Hetland ML
- Subjects
- Humans, Female, Follow-Up Studies, Prospective Studies, C-Reactive Protein, Osteitis drug therapy, Antirheumatic Agents therapeutic use, Arthritis, Rheumatoid diagnostic imaging, Arthritis, Rheumatoid drug therapy, Synovitis diagnostic imaging, Synovitis drug therapy
- Abstract
Objective: To identify predictors of flare in a 2-year follow-up study of patients with rheumatoid arthritis (RA) in sustained clinical remission tapering towards withdrawal of biological disease-modifying anti-rheumatic drugs (bDMARDs)., Methods: Sustained clinical remission was defined as Disease Activity Score for 28 joints (DAS28)-C reactive protein (CRP) ≤2.6 without radiographic progression for >1 year. bDMARDs were tapered according to a mandatory clinical guideline to two-thirds of standard dose at baseline, half of dose at week 16 and discontinuation at week 32. Prospective assessments for 2 years included clinical evaluation, conventional radiography, ultrasound and MRI for signs of inflammation and bone changes. Flare was defined as DAS28-CRP ≥2.6 with ∆DAS28-CRP ≥1.2 from baseline. Baseline predictors of flare were assessed by logistic regression analyses., Results: Of 142 included patients, 121 (85%) flared during follow-up of which 86% regained remission within 24 weeks after flare. Patients that flared were more often rheumatoid factor positive, had tried more bDMARDs and had higher baseline ultrasound synovitis sum scores than those not flaring. For patients on standard dose, predictors of flare within 16 weeks after reduction to two-thirds of standard dose were baseline MRI-osteitis (OR 1.16; 95% CI 1.03 to 1.33; p=0.014), gender (female) (OR 6.71; 95% CI 1.68 to 46.12; p=0.005) and disease duration (OR 1.06; 95% CI 1.01 to 1.11; p=0.020). Baseline predictors for flare within 2 years were ultrasound grey scale synovitis sum score (OR 1.19; 95% CI 1.02 to 1.44; p=0.020) and number of previous bDMARDs (OR 4.07; 95% CI 1.35 to 24.72; p=0.007)., Conclusion: The majority of real-world patients with RA tapering bDMARDs flared during tapering, with the majority regaining remission after stepwise dose increase. Demographic and imaging parameters (MR-osteitis/ultrasound greyscale synovitis) were independent predictors of immediate flare and flare overall and may be of importance for clinical decision-making in patients eligible for tapering., Competing Interests: Competing interests: LT: Speakers fee from Janssen, Roche, Novartis, Pfizer, UCB and Eli-Lilly, consultancy fee from Janssen. MO: research support, consultancy fees and/or speaker fees form Abbvie, BMS, Boehringer-Ingelheim, Celgene, Eli-Lilly, Galapagos, Gilead, Hospira, Janssen, Merck, Novartis, Novo, Orion, Pfizer, Regeneron, Roche, Sandoz, Sanofi and UCB. LJ: Speakers fees and consultancy fees from AbbVie, Eli-Lilly, and Novartis. UMO: consultancy fees from Eli-Lilly, Roche, Novartis, speakers fee from Roche. SK: research support from AbbVie, MSD and Novartis. DG: Speakers fee from Eli-Lilly; AH: speakers fee from Eli-Lilly; KA: speakers fees and advisory board membership fees from AbbVie, Cellgene, Pfizer, Novartis, Roche, Berlin Chemie, Eli-Lilly and MSD; MB: research support, consultancy fees and/or speaker fees from Image Analysis Group, Esaote, Abbvie, Celgene, Eli-Lilly, Janssen, Novartis, Pfizer, UCB, Novo, GSK, Takeda, Geurbet, Biogen, Radiobotics, Chondrometrics. MLH: grants from Bristol-Myers Squibb, AbbVie, Roche and Novartis, grants and personal fees from MSD, Biogen, and Pfizer, and personal fees from Eli-Lilly, Orion Pharma, CellTrion, Samsung Bioepis, Janssen Biologics B.V., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
132. Compartmentalized dendritic plasticity during associative learning.
- Author
-
d'Aquin S, Szonyi A, Mahn M, Krabbe S, Gründemann J, and Lüthi A
- Subjects
- Animals, Fear physiology, Learning physiology, Neuronal Plasticity physiology, Neurons physiology, Amygdala physiology, Conditioning, Classical physiology
- Abstract
Experience-dependent changes in behavior are mediated by long-term functional modifications in brain circuits. Activity-dependent plasticity of synaptic input is a major underlying cellular process. Although we have a detailed understanding of synaptic and dendritic plasticity in vitro, little is known about the functional and plastic properties of active dendrites in behaving animals. Using deep brain two-photon Ca
2+ imaging, we investigated how sensory responses in amygdala principal neurons develop upon classical fear conditioning, a form of associative learning. Fear conditioning induced differential plasticity in dendrites and somas regulated by compartment-specific inhibition. Our results indicate that learning-induced plasticity can be uncoupled between soma and dendrites, reflecting distinct synaptic and microcircuit-level mechanisms that increase the computational capacity of amygdala circuits.- Published
- 2022
- Full Text
- View/download PDF
133. Doppler ultrasound predicts successful discontinuation of biological DMARDs in rheumatoid arthritis patients in clinical remission.
- Author
-
Terslev L, Brahe CH, Hetland ML, Georgiadis S, Ellegaard K, Juul L, Huynh T, Døhn UM, Fana V, Møller T, Krabbe S, Ørnbjerg LM, Glinatsi D, Røgind H, Hansen A, Nørregaard J, Jacobsen S, Jensen DV, Manilo N, Asmussen K, Boesen M, Rastiemadabadi Z, Morsel-Carlsen L, Møller JM, Krogh NS, and Østergaard M
- Subjects
- Aged, Arthritis, Rheumatoid drug therapy, Female, Follow-Up Studies, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Predictive Value of Tests, Radiography, Retrospective Studies, Time Factors, Algorithms, Antirheumatic Agents therapeutic use, Arthritis, Rheumatoid diagnosis, Biological Products therapeutic use, Remission Induction methods, Ultrasonography, Doppler methods, Withholding Treatment
- Abstract
Objective: To assess the ability of ultrasound to predict successful tapering and successful discontinuation of biological DMARDs (bDMARDs) at the 2-year follow-up in RA patients in sustained remission., Methods: Patients in sustained remission (DAS28-CRP ≤ 2.6) and with no radiographic progression the previous year tapered bDMARDs according to a standardized regime. A total of 119 of these patients were included in this ultrasound substudy. At baseline, clinical assessment, MRI, X-ray and ultrasound of 24 joints were performed. Ultrasound-detected synovitis was defined and scored 0-3 using the OMERACT scoring system at the joint level for both grey-scale and Doppler activity. Sum scores for each ultrasound modality were calculated for 24 joints at the patient level. The final state of treatment was assessed after 2 years. The predictive value of ultrasound measures for successful tapering and discontinuation at the 2-year follow-up was assessed via logistic regression analyses., Results: Negative IgM-RF [odds ratio (OR) = 0.29, 95% CI: 0.10-0.85; P = 0.024] and lower Doppler sum score of 24 joints (OR = 0.44, 95% CI: 0.15, 0.87; P = 0.014) were independent predictors for successful discontinuation of bDMARDs at the 2-year follow-up. The predictive value of the Doppler sum score was independent of MRI findings. Previous numbers of bDMARDs were predictive of successful tapering (OR = 0.58, 95% CI: 0.35, 0.91; P = 0.018), whereas ultrasound was not. Clinical parameters were not predictive of successful tapering/discontinuation., Conclusion: Doppler sum score was an independent predictor for successful discontinuation of bDMARDs at the 2-year follow-up-the odds for achieving successful discontinuation decreased by 56% per one-unit increase in Doppler sum score. Ultrasound could not predict successful tapering., (© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2021
- Full Text
- View/download PDF
134. The Value of Magnetic Resonance Imaging for Assessing Disease Extent and Prediction of Relapse in Early Peripheral Spondyloarthritis.
- Author
-
Renson T, Carron P, De Craemer AS, Deroo L, de Hooge M, Krabbe S, Jans L, Østergaard M, Elewaut D, and Van den Bosch F
- Subjects
- Adult, Disease Progression, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Ultrasonography, Young Adult, Enthesopathy diagnostic imaging, Hip Joint diagnostic imaging, Knee Joint diagnostic imaging, Spondylarthritis diagnostic imaging, Synovitis diagnostic imaging
- Abstract
Objective: This study was undertaken to assess the inflammatory burden in peripheral spondyloarthritis (SpA) by magnetic resonance imaging (MRI) of the legs in an early remission-induction strategy study of tumor necrosis factor (TNF) blockade. Furthermore, we sought to determine the value of MRI to predict disease relapse versus sustained remission after treatment discontinuation., Methods: Thirty-two patients with early peripheral SpA with involvement of the legs determined on clinical examination and confirmed by ultrasonography (US) participated in a remission-induction trial of a TNF inhibitor (TNFi). Patients underwent MRI of the joints and entheses of the legs at baseline and at clinical remission, after which TNFi treatment was withdrawn. Images were evaluated for joint effusion, joint osteitis, entheseal soft tissue inflammation, and entheseal osteitis., Results: Joint effusion and enthesitis on clinical examination and US correlated well with MRI abnormalities. In addition, a substantial amount of subclinical involvement was seen on MRI, mainly in the ankle joints and heel entheses. Inflammation scores were markedly lower in the subclinically involved joints and entheses versus those that were clinically involved (P values ranged from 0.01 to <0.001). Inflammatory load on MRI decreased significantly upon TNFi treatment (P < 0.001). Whereas 80% of the joints that were clinically involved at baseline showed no effusion on remission MRI, 2 of 3 entheses involved at baseline showed residual inflammation. In addition, patients who experienced a relapse after treatment discontinuation displayed more entheseal soft tissue inflammation on remission MRI compared to those who maintained drug-free remission (P = 0.028)., Conclusion: Our findings delineate a differential response of synovitis and enthesitis, with enthesitis on MRI being less responsive to TNFi treatment. Furthermore, residual entheseal inflammation might be indicative of the need for continuous therapy., (© 2021, American College of Rheumatology.)
- Published
- 2021
- Full Text
- View/download PDF
135. Risk of serious infections in arthritis patients treated with biological drugs: a matched cohort study and development of prediction model.
- Author
-
Krabbe S, Grøn KL, Glintborg B, Nørgaard M, Mehnert F, Jarbøl DE, Østergaard M, and Hetland ML
- Subjects
- Adult, Aged, Antibodies, Monoclonal, Humanized therapeutic use, Area Under Curve, Case-Control Studies, Clinical Decision Rules, Cohort Studies, Female, Hospitalization, Humans, Logistic Models, Male, Middle Aged, Proportional Hazards Models, ROC Curve, Rituximab therapeutic use, Severity of Illness Index, Spondylarthropathies drug therapy, Ustekinumab therapeutic use, Antirheumatic Agents therapeutic use, Arthritis, Psoriatic drug therapy, Arthritis, Rheumatoid drug therapy, Biological Products therapeutic use, Infections epidemiology, Tumor Necrosis Factor Inhibitors therapeutic use
- Abstract
Objectives: Serious infection is a concern for patients with inflammatory joint diseases treated with biological drugs (bDMARDs). The objectives were to compare risk of serious infection, defined as infection leading to hospitalization, in patients initiating bDMARD treatment with that in the general population and, second, to develop a simple clinical prediction model and to obtain risk estimates for individual patients., Methods: This was a matched-cohort study based on nationwide registries in Denmark. Patients with RA, axial SpA and PsA initiating first bDMARD monitored in the DANBIO registry were matched 1:10 by age, gender and postal code with controls from the general population. The risk of serious infection during 12 months' follow-up was assessed with Cox regression. Prediction models were developed using logistic regression and compared using area under the receiver operating characteristic curve (AUC)., Results: We included 11 372 patients and 113 715 controls. During follow-up, 522 patients (4.6%) and 1434 controls (1.3%) developed a serious infection (hazard ratio 3.7, 95% CI 3.4, 4.1). Age-stratified risk was largely similar across diagnoses. A simple prediction model, the 'DANBIO infection risk score', based on age and a count of six clinical risk factors had moderate discriminative power (internal validation: AUC 0.69) that was comparable to that of the existing RABBIT (Rheumatoide Arthritis Beobachtung der BIologika-Therapie) Risk Score (external validation: AUC 0.68)., Conclusion: Patients with inflammatory joint diseases initiating bDMARD treatment had a four times increased risk of serious infection compared with the general population. A simple prediction model, feasible for shared decision-making, was developed to obtain risk estimates for individual patients., (© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2021
- Full Text
- View/download PDF
136. Arthritis and enthesitis in the hip and pelvis region in spondyloarthritis - OMERACT validation of two whole-body MRI methods.
- Author
-
Wetterslev M, Lambert RG, Maksymowych WP, Eshed I, Pedersen SJ, Bird P, Stoenoiu MS, Krabbe S, Mathew AJ, Foltz V, Gandjbakhch F, Paschke J, De Marco G, Marzo-Ortega H, Carron P, Poulsen AE, Jaremko JL, Conaghan PG, and Østergaard M
- Subjects
- Humans, Magnetic Resonance Imaging, Pelvis, Reproducibility of Results, Severity of Illness Index, Spondylarthritis diagnostic imaging
- Abstract
Objective: To validate reliability, correlation and responsiveness of two whole-body MRI scores for the hip/pelvis region in spondyloarthritis., Methods: Assessment of hip/pelvis inflammation in 4 multi-reader exercises using the OMERACT MRI Whole-body score for Inflammation in Peripheral joints and Entheses (MRI-WIPE) and Hip Inflammation Magnetic Resonance Imaging Scoring System (HIMRISS)., Results: In exercises 3-4 (11/20 cases, respectively; 9 readers) reliability was mostly good for the 3 best calibrated readers. Median pairwise single-measure ICC for status were 0.58-0.65 (WIPE-osteitis), 0.10-0.88 (HIMRISS-osteitis) and for status/change 0.38-0.72/0.52-0.60 (WIPE-synovitis/effusion) and 0.68-0.89/0.78-0.85 (HIMRISS-synovitis/effusion). SRM was 1.23 for WIPE-osteitis, while lower for WIPE-synovitis/effusion and HIMRISS., Conclusion: MRI-WIPE and HIMRISS may after further validation be useful in future spondyloarthritis trials., Competing Interests: Declaration of Competing Interest None., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
137. Joint and entheseal inflammation in the knee region in spondyloarthritis - reliability and responsiveness of two OMERACT whole-body MRI scores.
- Author
-
Wetterslev M, Maksymowych WP, Lambert RG, Eshed I, Pedersen SJ, Stoenoiu MS, Krabbe S, Bird P, Foltz V, Mathew AJ, Gandjbakhch F, Paschke J, Carron P, De Marco G, Marzo-Ortega H, Poulsen AE, Jaremko JL, Conaghan PG, and Østergaard M
- Subjects
- Humans, Inflammation diagnostic imaging, Knee Joint diagnostic imaging, Magnetic Resonance Imaging, Reproducibility of Results, Severity of Illness Index, Spondylarthritis complications, Spondylarthritis diagnostic imaging, Synovitis diagnostic imaging
- Abstract
Objective: To perform region-based development of whole-body MRI through validation of knee region scoring systems in spondyloarthritis (SpA)., Methods: Assessment of knee inflammatory pathologies using 2 systems, OMERACT MRI Whole-body score for Inflammation in Peripheral joints and Entheses (MRI-WIPE) and Knee Inflammation MRI Scoring System (KIMRISS), in 4 iterative multi-reader exercises., Results: In the final exercise, reliability was mostly good for readers with highest agreement in previous exercise. Median pairwise single-measure ICCs for osteitis and synovitis/effusion status/change were 0.71/0.48 (WIPE-osteitis), 0.48/0.77 (WIPE-synovitis/effusion), 0.59/0.91 (KIMRISS-osteitis) and 0.92/0.97 (KIMRISS-synovitis/effusion). SRMs were 0.74 (WIPE-synovitis/effusion) and 0.78 (KIMRISS-synovitis/effusion)., Conclusion: MRI-WIPE and KIMRISS may both be useful in SpA whole-body evaluation studies., Competing Interests: Declaration of Competing Interest WPM is Chief Medical Officer CARE Arthritis Limited and has acted as a paid consultant/participated in advisory boards for AbbVie, Boehringer Ingelheim, Celgene, Eli Lilly, Galapagos, Janssen, Novartis, Pfizer and UCB; received research and/or educational grants from AbbVie, Novartis, Pfizer and UCB; received speaker fees from AbbVie, Janssen, Novartis, Pfizer and UCB. RGWL has received consulting fees from CARE Arthritis, Parexel and Pfizer. SJP has been an advisory board member for AbbVie and Novartis; received research support from AbbVie, MSD, and Novartis; received speaker fees from MSD, Pfizer, AbbVie, Novartis and UCB. PB participated in advisory boards and received speaker fees from Janssen, Abbvie, UCB, Celgene, BMS, Novartis, Pfizer, Gilead, Eli-Lilly. PC has received research grants from UCB, MSD and Pfizer; speaker/consultant for Pfizer, MSD, Novartis, BMS, AbbVie, UCB, Eli Lilly, Gilead and Celgene. HMO has received research grants from Janssen and Novartis; honoraria/speaker fees from AbbVie, Celgene, Janssen, Lilly, Novartis, Pfizer, Takeda and UCB. PGC has received speaker or consultancy fees from AbbVie, AstraZeneca, BMS, Eli Lilly, EMD Serono, Flexion Therapeutics, Galapagos, Gilead, Novartis, Pfizer and Stryker. MØ has received research support, consultancy fees and/or speaker fees from Abbvie, BMS, Boehringer-Ingelheim, Celgene, Eli-Lilly, Hospira, Janssen, Merck, Novartis, Pfizer, Regeneron, Roche, Sandoz, Sanofi and UCB. MW, IE, MSS, SK, VF, AJM, FG, JP, GDM, AEFP and JLJ have no declarations of interest for this work., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
138. Application of the OMERACT Grey-scale Ultrasound Scoring System for salivary glands in a single-centre cohort of patients with suspected Sjögren's syndrome.
- Author
-
Fana V, Dohn UM, Krabbe S, and Terslev L
- Subjects
- Humans, Parotid Gland diagnostic imaging, Salivary Glands diagnostic imaging, Sensitivity and Specificity, Ultrasonography, Sjogren's Syndrome diagnostic imaging
- Abstract
Aim: To describe salivary gland involvement in patients suspected of Sjögren's syndrome (SS) using the OMERACT Ultrasound Scoring System for SS. Next, using different ultrasound cut-offs, to assess the performance of the scoring system for diagnosis and fulfilment of 2016 ACR/EULAR SS classification criteria., Methods: All patients referred to our department with a suspicion of SS in a 12-month period were included. All underwent grey-scale ultrasound of the parotid and submandibular glands prior to clinical examination, Schirmer's test, unstimulated salivary flow, blood samples including autoantibody analysis. Labial biopsy was performed according to clinicians' judgement. Images of the four glands were scored 0-3 according to the scoring system and a consensus score was obtained using a developed ultrasound atlas., Results: Of the 134 patients included in the analysis, 43 were diagnosed with primary SS (pSS) and all fulfilled the 2016 American College of Rheumatology (ACR)/EULAR classification criteria. More patients with pSS compared with non-pSS had score ≥2 in at least one gland (72% vs 13%; p<0.001). In patients with score ≥2 in any gland, significantly more had positive autoantibodies, sialometry, Schirmer's test and positive labial biopsy compared with those with scores ≤1. The best ultrasound cut-off value for diagnosing pSS was ≥1 gland with a score ≥2 (sensitivity=0.72, specificity=0.91)., Conclusion: The OMERACT Ultrasound Scoring System showed good sensitivity (0.72) and excellent specificity (0.91) for fulfilling 2016 ACR/EULAR criteria using cut-off score >2 in at least one gland. Our data supports the use of ultrasound for diagnosing pSS and supports incorporation of ultrasound in the classification criteria., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2021
- Full Text
- View/download PDF
139. Whole-body Magnetic Resonance Imaging in Psoriatic Arthritis, Rheumatoid Arthritis, and Healthy Controls: Interscan, Intrareader, and Interreader Agreement and Distribution of Lesions.
- Author
-
Poulsen AEF, Axelsen MB, Poggenborg RP, Eshed I, Krabbe S, Glinatsi D, Møller JM, and Østergaard M
- Subjects
- Humans, Magnetic Resonance Imaging, Observer Variation, Reproducibility of Results, Severity of Illness Index, Whole Body Imaging, Arthritis, Psoriatic diagnostic imaging, Arthritis, Rheumatoid diagnostic imaging
- Abstract
Objective: Whole-body MRI (WBMRI) is a promising technique for monitoring patients' global disease activity in inflammatory joint diseases. The validation of WBMRI is limited; no studies have evaluated the test-retest agreement (interscan agreement) and only a few have assessed the intra- and interreader agreement. Therefore, we first examined the interscan agreement of WBMRI in patients with psoriatic arthritis (PsA), rheumatoid arthritis (RA), and healthy controls (HC); and second, we evaluated the intra- and interreader agreement and agreement with conventional hand MRI and determined the distribution of lesions., Methods: WBMRI was performed twice at a 1-week interval in 14 patients with PsA, 10 with RA, and 16 HC. Images were anonymized and read in pairs with unknown chronological order by experienced readers according to the Outcome Measures in Rheumatology (OMERACT) WBMRI, Canada-Denmark MRI, and the RA MRI scoring system (RAMRIS) and the PsA MRI scoring system (PsAMRIS). Ten image sets were reanonymized for assessment of intra- and interreader agreement. Agreement was calculated on lesion level by percentage exact agreement (PEA) and Cohen κ, and for sum scores by absolute agreement, single-measure intraclass correlation coefficient (ICC)., Results: WBMRI of the spine and peripheral joints and entheses generally showed moderate to almost perfect interscan agreement with PEA ranging from 95% to 100%, κ 0.71-1.00, and ICC 0.95 to 1.00. Intra- and interreader data generally showed moderate to almost perfect agreement. Agreement with conventional MRI varied. More lesions were found in patients than in HC., Conclusion: WBMRI showed good interscan agreement, implying that repositioning of the patient between examinations does not markedly affect scoring of lesions. Intra- and interreader agreement were moderate to almost perfect., (Copyright © 2021 by the Journal of Rheumatology.)
- Published
- 2021
- Full Text
- View/download PDF
140. Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission.
- Author
-
Terslev L, Brahe CH, Østergaard M, Fana V, Ammitzbøll-Danielsen M, Møller T, Krabbe S, Hetland ML, and Døhn UM
- Subjects
- Humans, Inflammation drug therapy, Remission Induction, Severity of Illness Index, Ultrasonography, Ultrasonography, Doppler, Antirheumatic Agents therapeutic use, Arthritis, Rheumatoid diagnostic imaging, Arthritis, Rheumatoid drug therapy, Synovitis diagnostic imaging, Synovitis drug therapy
- Abstract
Background: Subclinical synovitis by ultrasound is a frequent finding in rheumatoid arthritis (RA) patients in remission and has been shown to be related to erosive progression, risk of flare and unsuccessful drug tapering, but it has not been investigated how a DAS28 T2T-steered strategy in routine care affects the presence of subclinical synovitis in RA patients in remission. The aim of the current study was to investigate the presence of ultrasound-detected subclinical inflammation in RA patients in long-term remission receiving either biological or conventional disease-modifying anti-rheumatic drugs (bDMARD/csDMARD) and, finally, to investigate the presence of ultrasound remission using different ultrasound remission criteria., Methods: Eighty-seven RA patients (42 patients receiving bDMARD and 45 csDMARD) received DAS28-CRP-steered treatment in routine care and had achieved DAS28-CRP-remission for > 1 year without radiographic progression. Twenty-four joints were scored 0-3 by ultrasound (elbows, wrists, knees, ankles, metacarpophalangeal and metatarsophalangeal joints 2-5) for grey-scale synovial hypertrophy (GS) and colour Doppler activity (CD) using the OMERACT scoring system. Ultrasound remission was defined as strict (GS score = 0 and CD score = 0), semi-strict (GS score < 1 and Doppler score = 0) and Doppler remission (Doppler score = 0)., Results: No differences between treatment groups were found for GS sum score and Doppler sum score (median (range) 6 (0-19) and 0 (0-12), respectively). A Doppler score > 0 in at least 1 joint was seen in 44%, a GS score > 1 in at least 1 joint in 93% and a GS score > 2 in at least 1 joint in 54% of patients. Strict ultrasound remission was only observed in bDMARD patients (7%; p = 0.01). Thirty-seven per cent were in semi-strict ultrasound remission and 56% in Doppler remission (no significant difference between groups) with similar results across the subgroups of patients who also fulfilled the ACR-EULAR Boolean-, CDAI- and SDAI-remission criteria., Conclusions: Ultrasound frequently detected subclinical synovitis in RA patients in longstanding DAS28-remission obtained through a DAS28-CRP-steered strategy. This was independent of treatment and applied ultrasound remission criteria. Strict ultrasound remission was rare.
- Published
- 2021
- Full Text
- View/download PDF
141. Axial involvement in patients with early peripheral spondyloarthritis: a prospective MRI study of sacroiliac joints and spine.
- Author
-
Renson T, Carron P, De Craemer AS, Deroo L, de Hooge M, Krabbe S, Jans L, Chen M, Østergaard M, Van den Bosch FE, and Elewaut D
- Subjects
- Adult, Antibodies, Monoclonal therapeutic use, Arthritis, Psoriatic complications, Arthritis, Psoriatic drug therapy, Arthritis, Psoriatic physiopathology, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Sacroiliac Joint diagnostic imaging, Sacroiliitis complications, Sacroiliitis physiopathology, Spondylarthropathies diagnostic imaging, Spondylarthropathies drug therapy, Spondylarthropathies physiopathology, Tumor Necrosis Factor Inhibitors therapeutic use, Arthritis, Psoriatic diagnostic imaging, Bone Marrow diagnostic imaging, Edema diagnostic imaging, Sacroiliitis diagnostic imaging
- Abstract
Objectives: To assess axial involvement on MRI in early peripheral spondyloarthritis (pSpA) and to evaluate whether axial inflammation predicts relapse on treatment withdrawal., Methods: Fifty-six patients with early, active, newly diagnosed pSpA underwent MRI of the sacroiliac joints (SIJs) and spine prior to golimumab initiation. At sustained clinical remission of pSpA, treatment was withdrawn and a second MRI was performed. Bone marrow oedema (BME) was scored by three readers according to the Spondyloarthritis Research Consortium of Canada (SPARCC) method. Scores were compared with an axial spondyloarthritis cohort (Belgian Arthritis and Spondylitis cohort). Structural lesions were assessed using a similar method. Furthermore, fulfilment of the Assessment of Spondyloarthritis International Society (ASAS) definition of a positive MRI for sacroiliitis was assessed. Spinal images were evaluated for BME and structural lesions using the Canada-Denmark MRI spine scoring system by two readers., Results: Thirty-six per cent showed SIJ BME at baseline, all fulfilling the ASAS definition of sacroiliitis. No association with back pain was found. Twenty-one per cent displayed SIJ structural lesions. Spinal BME was limited: the median inflammation scores were low and no patients had ≥5 inflammatory corner lesions. On clinical remission, a significant decrease in SIJ SPARCC scores was detected. On clinical remission, no significant differences in SIJ SPARCC scores were noted between patients relapsing and those maintaining remission after treatment discontinuation., Conclusion: In patients with early pSpA, a surprisingly high prevalence of sacroiliitis on MRI was observed; SPARCC scores decreased significantly on tumour necrosis factor inhibition. Residual inflammation on MRI was not predictive of relapse of peripheral manifestations. No relevant inflammatory spinal involvement was detected. Collectively, our findings suggest a higher inflammatory burden in patients with early pSpA than anticipated., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2021
- Full Text
- View/download PDF
142. Validation of assessment methods for the apparent diffusion coefficient in a clinical trial of axial spondyloarthritis patients treated with golimumab.
- Author
-
Møller JM, Østergaard M, Thomsen HS, Krabbe S, Sørensen IJ, Jensen B, Madsen OR, Klarlund M, and Pedersen SJ
- Abstract
Purpose: To compare three region-of-interest (ROI) settings in the assessment of ADC in a clinical trial, and to evaluate the effectiveness of ADC in assessing therapy-induced changes and predicting clinical outcomes., Methods: In a 52-week clinical trial involving patients with axial spondyloarthritis, mean sacroiliac joint (SIJ) ADC measurements using structured, lesion-based, and index-lesion ROI-settings were assessed at baseline and weeks 4, 16, and 52. Variation among the three ROI-settings, correlations with Spondyloarthritis Research Consortium of Canada (SPARCC)-bone marrow edema (BME) SIJ inflammation indices, standardized response means (SRMs), and effectiveness in predicting clinical outcomes were analyzed., Results: Forty of the 53 patients had at least one assessable SIJ lesion on ADC at baseline. The mean of the structured ROI ADC (ADC
struc ) was 230 μmm2 /s (standard deviation [SD] = 120). This was significantly lower ( p < 0.01) than the means of the lesion-based ROI ADC (ADClesion = 420 μmm2 /s, SD = 210) and index-lesion ROI ADC (ADCindex = 471 μmm2 /s, SD = 278), which did not differ. ADC correlated with SPARCC-BME scores at baseline ( p < 0.01) as did changes over time in ADC- and SPARCC-BME ( p <0.05). At all follow-up time points, responsiveness was high for ADClesion (SRM > 0.92) and ADCindex (SRM > 0.87) while moderate for ADCstruc (SRM:0.54-0.67). Baseline ADC and changes in ADC did not predict clinical outcomes., Conclusions: Lesion-based and index-lesion ROI ADC could both be used to evaluate the effectiveness of tumor necrosis factor inhibitor therapy. None of the methods could predict clinical outcomes., (© 2020 The Author(s).)- Published
- 2020
- Full Text
- View/download PDF
143. Novel whole-body magnetic resonance imaging response and remission criteria document diminished inflammation during golimumab treatment in axial spondyloarthritis.
- Author
-
Krabbe S, Eshed I, Sørensen IJ, Møller J, Jensen B, Madsen OR, Klarlund M, Pedersen SJ, and Østergaard M
- Subjects
- Adult, Cohort Studies, Enthesopathy, Female, Humans, Male, Remission Induction, Sacroiliac Joint diagnostic imaging, Time Factors, Treatment Outcome, Anti-Inflammatory Agents therapeutic use, Antibodies, Monoclonal therapeutic use, Joints diagnostic imaging, Magnetic Resonance Imaging methods, Spondylarthritis diagnostic imaging, Spondylarthritis drug therapy, Whole Body Imaging methods
- Abstract
Objectives: To investigate criteria for treatment response and remission in patients with axial SpA as assessed by whole-body magnetic resonance imaging (WB-MRI) of axial and peripheral joints and entheses during treatment with golimumab., Methods: We performed an investigator-initiated cohort study of 53 patients who underwent WB-MRI at weeks 0, 4, 16 and 52 after initiation of golimumab. Images were assessed according to the Spondyloarthritis Research Consortium of Canada MRI SI joint inflammation index, Canada-Denmark MRI spine inflammation score and the MRI peripheral joints and entheses inflammation index., Results: At weeks 4, 16 and 52, WB-MRI demonstrated an at least 50% reduction of MRI inflammation of the sacroiliac joints in 16, 29 and 32 (30%, 55% and 60%) patients, of the spine in 20, 30 and 31 (38%, 57% and 58%) patients and of peripheral joints and entheses in 8, 17 and 15 (15%, 32% and 28%) patients, respectively. The BASDAI50 response was achieved by 29, 31 and 31 (55%, 58% and 58%) patients, while ASDAS clinically important improvement (ASDAS-CII) was achieved by 37, 40 and 34 (70%, 75% and 64%) patients. WB-MRI remission criteria for spine, sacroiliac joints and peripheral joints and entheses were explored; total WB-MRI remission was attained by 2, 6 and 3 (4%, 11% and 6%) patients. At week 16, among 35 patients with an at least 50% reduction in the MRI Axial Inflammation Index (sacroiliac joint and spine inflammation), 29 (83%) achieved BASDAI50 and 35 (100%) achieved ASDAS-CII; among 16 patients with MRI axial inflammation non-response, 14 (88%) were BASDAI50 non-responders and 11 (69%) did not achieve ASDAS-CII., Conclusion: WB-MRI demonstrated a significant reduction of inflammation in both the spine, sacroiliac joints and peripheral joints and entheses during golimumab treatment. Few patients achieved total WB-MRI remission. Combining spinal and sacroiliac joint inflammation in an MRI Axial Inflammation Index increased the ability to capture response., Trial Registration: ClinicalTrials.gov, http://clinicaltrials.gov, NCT02011386., (© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2020
- Full Text
- View/download PDF
144. Folinic acid alleviates side effects of methotrexate in arthritis patients with side effects despite folic acid supplementation: an observational cohort study.
- Author
-
Fischer EA, Hetland ML, and Krabbe S
- Subjects
- Aged, Arthritis, Psoriatic drug therapy, Chemical and Drug Induced Liver Injury etiology, Cohort Studies, Drug Substitution, Female, Humans, Male, Middle Aged, Nausea chemically induced, Oral Ulcer chemically induced, Retrospective Studies, Rheumatic Fever drug therapy, Treatment Failure, Antirheumatic Agents adverse effects, Arthritis drug therapy, Chemical and Drug Induced Liver Injury drug therapy, Folic Acid therapeutic use, Leucovorin therapeutic use, Methotrexate adverse effects, Nausea drug therapy, Oral Ulcer drug therapy, Vitamin B Complex therapeutic use
- Published
- 2020
- Full Text
- View/download PDF
145. Identifying air pollution source impacts in urban communities using mobile monitoring.
- Author
-
Deshmukh P, Kimbrough S, Krabbe S, Logan R, Isakov V, and Baldauf R
- Abstract
With increasing population, rapid urbanization, and increased migration to cities, the local impacts of increasing transportation and industrial-related air pollution are of growing concern worldwide. Elevated air pollution concentrations near these types of sources have been linked to adverse health effects including acute and chronic respiratory and cardiovascular diseases. Mobile monitoring has proven to be a useful technique to characterize spatial variability of air pollution in urban areas and pollution concentration gradients from specific sources. A study was conducted in the Kansas City, Kansas (USA) metropolitan area using mobile monitoring to characterize the spatial variability and gradients of air pollutants to identify the contribution of multiple sources on community-level air quality in a complex urban environment. Measurements focused on nitrogen dioxide (NO
2 ), black carbon (BC), and ultrafine particulate matter (UFP). Mobile monitoring showed that median concentrations of these pollutants ranged by up to a factor of three between the communities, with individual measurements ranging over an order of magnitude within the community. Evaluating these air quality measurements with wind direction data highlighted the influence of specific and combinations of air pollution sources on these elevated concentrations, which can provide valuable information to environmental and public health officials in prioritizing and implementing cost-effect air quality management strategies to reduce exposures for urban populations., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2020. Published by Elsevier B.V.)- Published
- 2020
- Full Text
- View/download PDF
146. Scoring magnetic resonance imaging (MRI) inflammation and structural lesions in sacroiliac joints of patients with axial spondyloarthritis: assessment of all MRI slices of the cartilaginous compartment versus standardized six or five slices.
- Author
-
Krabbe S, Kröber G, Pedersen SJ, Østergaard M, Møller JM, Sørensen IJ, Jensen B, Madsen OR, Klarlund M, and Weber U
- Subjects
- Adipose Tissue diagnostic imaging, Adolescent, Adult, Aged, Aged, 80 and over, Ankylosis diagnostic imaging, Antibodies, Monoclonal therapeutic use, Bone Marrow diagnostic imaging, Cartilage, Articular diagnostic imaging, Cortical Bone diagnostic imaging, Edema diagnostic imaging, Female, Humans, Inflammation, Magnetic Resonance Imaging methods, Male, Metaplasia, Middle Aged, Observer Variation, Sacroiliitis drug therapy, Spondylarthropathies drug therapy, Tumor Necrosis Factor Inhibitors therapeutic use, Young Adult, Sacroiliac Joint diagnostic imaging, Sacroiliitis diagnostic imaging, Spondylarthropathies diagnostic imaging
- Abstract
Objectives : The Spondyloarthritis Research Consortium of Canada (SPARCC) sacroiliac joint (SIJ) scoring system assesses six or five (6/5) semicoronal magnetic resonance imaging (MRI) slices for inflammation/structural lesions in patients with axial spondyloarthritis (axSpA). However, the cartilaginous SIJ compartment may be visible in a few additional slices. The objective was to investigate interreader reliability, sensitivity to change, and classification of MRI scans as positive or negative for various lesion types using an 'all slices' approach versus standard SPARCC scoring of 6/5 slices. Method : Fifty-three axSpA patients were treated with the tumour necrosis factor inhibitor golimumab and followed with serial MRI scans at weeks 0, 4, 16, and 52. The most anterior and posterior slices covering the cartilaginous compartment and the transitional slice were identified. Scores for inflammation, fat metaplasia, erosion, backfill, and ankylosis in the cartilaginous SIJ compartment were calculated for the 'all slices' approach and the 6/5 slices standard. Results : By the 'all slices' approach, three readers scored mean 7.2, 7.7, and 7.0 slices per MRI scan. Baseline and change scores for the various lesion types closely correlated between the two approaches (Pearson's rho ≥ 0.95). Inflammation score was median 13 (interquartile range 6-21, range 0-49) for 6/5 slices versus 14 (interquartile range 6-23, range 0-69) for all slices at baseline. Interreader reliability, sensitivity to change, and classification of MRI scans as positive or negative for various lesion types were similar. Conclusion : The standardized 6/5 slices approach showed no relevant differences from the 'all slices' approach and, therefore, is equally suited for monitoring purposes.
- Published
- 2020
- Full Text
- View/download PDF
147. High versus standard magnetic resonance image resolution of the cervical spine in patients with axial spondyloarthritis.
- Author
-
Krabbe S, Østergaard M, Sørensen IJ, Møller J, Jensen B, Madsen OR, and Pedersen SJ
- Subjects
- Adult, Cervical Vertebrae diagnostic imaging, Double-Blind Method, Female, Humans, Male, Image Interpretation, Computer-Assisted methods, Magnetic Resonance Imaging methods, Spondylarthritis diagnostic imaging
- Published
- 2020
- Full Text
- View/download PDF
148. Association between MRI findings and patient-reported outcomes in patients with rheumatoid arthritis in clinical remission and at relapse.
- Author
-
Glinatsi D, Brahe CH, Hetland ML, Ørnbjerg L, Krabbe S, Baker JF, Boesen M, Rastiemadabadi Z, Morsel-Carlsen L, Røgind H, Hansen A, Nørregaard J, Jacobsen S, Terslev L, Huynh TK, Manilo N, Jensen DV, Møller JM, Krogh NS, and Østergaard M
- Subjects
- Adult, Aged, Antirheumatic Agents administration & dosage, Arthritis, Rheumatoid drug therapy, Denmark, Drug Tapering, Female, Humans, Joints, Male, Middle Aged, Predictive Value of Tests, Recurrence, Remission Induction, Treatment Outcome, Arthritis, Rheumatoid diagnostic imaging, Magnetic Resonance Imaging, Patient Reported Outcome Measures
- Abstract
Objective: To investigate whether magnetic resonance imaging (MRI) pathologies in the wrist/hand of rheumatoid arthritis (RA) patients are associated with patient-reported outcomes (PROs) at clinical remission and relapse., Methods: Wrist/hand MRIs and wrists/hands/feet radiographs were obtained in 114 established RA patients in clinical remission, before tapering their biologic disease-modifying antirheumatic drugs. MRIs were assessed according to the Outcome Measures in Rheumatology (OMERACT) RA MRI score (RAMRIS) for inflammation (synovitis/tenosynovitis/bone marrow edema) and damage (bone erosion/joint space narrowing) at baseline (ie remission) and in case of a relapse (n = 70). Radiographs were assessed according to the Sharp/van der Heijde (SvH) method at baseline. These scores were assessed for associations with health assessment questionnaires (HAQ), visual analog scales (VAS global/pain), EuroQol-5 dimensions and Short-Form 36 physical and mental component summary (SF-36 PCS/MCS) using Spearman correlations, univariate/multivariable linear regression analyses and generalized estimating equations. Furthermore, MRI pathologies were assessed for association with specific hand-related HAQ items using Jonckheere trend tests., Results: Magnetic resonance imaging-assessed damage was associated with impaired HAQ and SF-36 PCS at remission and relapse (P < .01), independent of clinical and radiographic measures, and was also associated with most of the hand-related HAQ items (P < .03). In multivariate models including MRI, SvH scores were not associated with PROs. MRI-assessed inflammation was not associated with PROs at remission or relapse., Conclusion: Magnetic resonance imaging-assessed wrist/hand damage, but not inflammation, in patients with established RA is associated with patient-reported physical impairment at remission and relapse. The amount of damage in the wrist/hand is associated with reduced hand function., (© 2020 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
149. Atlas of the OMERACT Heel Enthesitis MRI Scoring System (HEMRIS).
- Author
-
Mathew AJ, Krabbe S, Eshed I, Lambert RG, Laredo JD, Maksymowych WP, Gandjbakhch F, Emad Y, Stoenoiu MS, Foltz V, Bird P, Carron P, Paschke J, Conaghan PG, Pedersen SJ, Glinatsi D, and Østergaard M
- Subjects
- Achilles Tendon pathology, Arthritis, Psoriatic complications, Arthritis, Psoriatic pathology, Clinical Trials as Topic, Enthesopathy etiology, Humans, Muscle, Skeletal pathology, Outcome Assessment, Health Care, Rheumatology standards, Spondylarthritis complications, Spondylarthritis pathology, Enthesopathy diagnostic imaging, Heel pathology, Magnetic Resonance Imaging methods, Research Design statistics & numerical data
- Abstract
Objective: Assessment of enthesitis, a key feature in spondyloarthritis (SpA) and psoriatic arthritis (PsA), using objective and sensitive methods is pivotal in clinical trials. MRI allows detection of both soft tissue and intra-osseous changes of enthesitis. This article presents an atlas for the Outcome Measures in Rheumatology (OMERACT) Heel Enthesitis Magnetic Resonance ImagingMRI Scoring System (HEMRIS)., Methods: Following a preliminary selection of potential examples of each grade, as per HEMRIS definitions, the images along with detailed definitions and reader rules were discussed at web-based, interactive meetings between the members of the OMERACT MRI in Arthritis Working Group., Results: Reference images of each grade of the MRI features to be assessed using HEMRIS, along with reader rules and recommended MRI sequences are depicted., Conclusion: The presented reference images can be used to guide scoring Achilles tendon and plantar fascia (plantar aponeurosis) enthesitis according to the OMERACT HEMRIS in clinical trials and cohorts in which MRI enthesitis is used as an outcome., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2020
- Full Text
- View/download PDF
150. Whole-body Magnetic Resonance Imaging Inflammation in Peripheral Joints and Entheses in Axial Spondyloarthritis: Distribution and Changes during Adalimumab Treatment.
- Author
-
Krabbe S, Eshed I, Sørensen IJ, Jensen B, Møller JM, Balding L, Madsen OR, Pedersen SJ, and Østergaard M
- Subjects
- Achilles Tendon diagnostic imaging, Adult, Enthesopathy complications, Female, Humans, Inflammation diagnostic imaging, Male, Middle Aged, Spondylitis, Ankylosing complications, Treatment Outcome, Adalimumab therapeutic use, Antirheumatic Agents therapeutic use, Enthesopathy diagnostic imaging, Joints diagnostic imaging, Magnetic Resonance Imaging methods, Spondylitis, Ankylosing diagnostic imaging, Spondylitis, Ankylosing drug therapy, Whole Body Imaging methods
- Abstract
Objective: To investigate the distribution of whole-body magnetic resonance imaging (WB-MRI) inflammatory lesions of peripheral joints and entheses, and their response to adalimumab (ADA) treatment and agreement with clinical measures of disease activity in patients with axial spondyloarthritis (axSpA)., Methods: Explorative analysis of an investigator-initiated randomized controlled trial of ADA. WB-MRI was performed at weeks 0, 6, 24, and 48. Detailed analyses of WB-MRI lesions in peripheral joints and entheses were performed, including agreement with clinical measures of disease activity., Results: WB-MRI inflammatory lesions were most frequently observed in the acromioclavicular, metatarsophalangeal, and wrist joints (> 10% of joints), and at the greater trochanter, calcaneal insertion of the Achilles tendon, and ischial tuberosity (> 15% of entheses). Inflammation resolved in ≥ 2/3 of involved sternoclavicular, metacarpophalangeal, first carpometacarpal, hip, and tarsometatarsal joints, and pubic symphyses and medial femoral condyles. In contrast, inflammation resolved in ≤ 1/6 of involved acromioclavicular joints, knee joints, and supraspinatus tendon insertions at humerus. Tenderness of joints and entheses agreed poorly with WB-MRI inflammation (κ < 0.40). Joint tenderness resolved more frequently in MRI-positive than MRI-negative joints (8/13, 62% vs 9/34, 26%) after 6 weeks of active treatment., Conclusion: Inflammatory lesions of peripheral joints and entheses in patients with predominantly axSpA, and changes therein, can be mapped using WB-MRI, and it may contribute to differentiate between inflammatory and noninflammatory joint tenderness. (Trial registration: ClinicalTrials NCT01029847).
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.